ID-IRC : 2114090633
ISMAILI Nabil
Professeur agrégé
Spécialité : Oncologie médicale
Faculté de Médecine Dentaire - UM6SS de Casablanca
Hôpital cheikh khalifa ibn zaid de Casablanca
Domaine de Maîtrise :
Recherche Clinique
Domaine d’intérêt :
Épidémiologie et Santé Publique, Essais Cliniques, Recherche Clinique
Les publications :
Chemotherapy in advanced bladder cancer: current status and future A rare bladder cancer–small cell carcinoma: review and update Concurrent chemoradiotherapy in adjuvant treatment of breast Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution Demographic, clinical, pathological, molecular, treatment characteristics and outcomes of nonmetastatic inflammatory breast cancer in Morocco: 2007 and 2008 Recent advances in targeted therapies in the treatment of HER2-positive metastatic breast cancer Trastuzumab in early breast cancer Management of breast cancer during COVID-19 pandemic in Morocco COVID-19 and Gynecological Cancers: A Summary of International Recommendations COVID-19 and gynecological cancers: A Moroccan point-of-view Treatment of Adult Soft Tissue Sarcomas: An Overview. Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meeting Abiraterone in Metastatic Prostate Cancer. Spectrum of EGFR mutation in lung adenocarcinoma in Morocco Editorial comment from Dr Ismaili to local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix. Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy? Outcome of recurrent and metastatic small cell carcinoma of the bladder Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients Primary intrapulmonary malignant peripheral nerve sheath tumor: A rare case COVID-19, Brachytherapy, and Gynecologic Cancers: a Moroccan Experience Neoadjuvant Chemotherapy: A New Standard for Muscle Invasive Bladder Cancer? Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In press. H COVID-19 and hematopoietic stem cell transplantation: Recommendations Epidemiology and outcome of cervical cancer in national institute of Morocco COVID-19 Recommendations for Patients with Cancer: The post-COVID-19 Era Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status Concurrent chemo-radiotherapy in the treatment of early breast cancer: Current status Bisphosphonates and innovative drugs in the prevention of skeletal complications secondary to metastatic prostate cancer Treatment of colorectal liver metastases Small cell cancer of the bladder: The Leon-Berard cancer centre experience . Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience Primary Nasopharyngeal non-Hodgkin lymphomas: a retrospective review of 26 Moroccan patientshttps://pubmed.ncbi.nlm.nih.gov/19919708/Case reportSmall cell carcinoma of the urinary bladder: a case report and review of the literature Management of anorectal melanoma: report of 17 cases and literature Breast cancer in moroccan young women: a retrospective study CommentTreatment trends and outcomes of small-cell carcinoma of the bladder: in regard to Koay et al. (Int J Radiat Oncol Biol Phys 2011 Oct 20) In regard to Rehman et al. Re: Modern outcomes of inflammatory breast cancer